In 1993, only 16,800 procedures were reported. That number jumped to 370,000 in 2009. Once offered only to patients who needed to lose more than 100 pounds, concerns about obesity-related conditions, such as diabetes and heart disease, have opened the procedure up to patients with a BMI as low as 30. An increase in cancer diagnoses and procedures is also expected to contribute to market growth.
Related Articles on Gastroenterology:
EndoChoice to Receive Georgia Bio Deal of the Year Award
Gastrointestinal Endoscopic Device Market Expected to Hit $2.7B by 2018
KY’s Jennie Stuart ASC Celebrates 5th Anniversary, Adds Barrett’s Esophagus Treatment
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
